America Pouchitis Treatment Market Overview 2023 Porters Five Forces Analysis And Consumer Demand By 2030
America pouchitis treatment market overview and analysis by treatment and end users - forecast till 2030. Pouchitis is one of the most common complications of ileal pouch-anal anastomosis (IPAA) surgery and has a significant adverse impact on the quality of life. Pouchitis is an inflammation of the surgically constructed pouch. Various therapies are recommended for the treatment of pouchitis such as antibiotics, budesonide enemas, probiotics, probiotics, butyrate suppositories, bismuth enemas, and others.
The main factors influencing the pouchitis treatment market are the increased requirement for ileal pouch-anal anastomosis surgery, chronic use of NSAIDs, rising prevalence of ulcerative colitis (UC), and expanding geriatric population.
However, the side effects of the available treatment options and stringent FDA regulations may hinder the growth of the market to an extent. Till now not even a single drug is approved by the FDA for the treatment of pouchitis. However, few are in clinical trials waiting for approval such as Alicaforsen by Atlantic Healthcare plc.
The America pouchitis treatment market is expected to grow at a CAGR of 4.8% during the forecast period 2022-2030.
Key Players in the Americas Pouchitis Treatment Market
Some of key the players in the Americas pouchitis treatment market are Pfizer, Abbott, Allergan Plc, Bayer, Takeda Pharmaceutical Company Limited, Alfa sigma, Atlantic Healthcare, Tillotts Pharma AG, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi, B. Braun Medical Inc., Valeant Pharmaceuticals, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Synergy Pharmaceuticals, Inc., Ardelyx, Inc., Sebela Pharmaceuticals, Probi, and others.
Segmentation
The America pouchitis treatment market size is segmented on the basis of treatment and end user.
On the basis of the treatment, the market is segmented into antibiotics, probiotics, and others. The antibiotic segment is further sub-segmented into ciprofloxacin, metronidazole, rifaximin, and others.
On the basis of the end -users, the market is segmented into hospitals & clinics, research institutes, and others.
Regional Analysis
On the basis of region, North America and South America are the two regions that make up the Americas pouchitis treatment market. Due to the high cost of healthcare and increased incidence of pouchitis, North America makes up a significant portion of the global market. As a result of the region's greater preference for high-quality treatment, healthcare spending has increased. Owing to the rising prevalence of pouchitis, numerous businesses, nonprofits, and governmental agencies are actively working to enhance the available therapies.
The Americas pouchitis market is driven by ongoing extensive research in the inflammatory bowel disease (IBD). The American Gastroenterological Association (AGA) has introduced several new research grants to support investigators studying inflammatory bowel disease (IBD) such as Takeda Pharmaceuticals research scholar awards in IBD, and Pfizer pilot research award in IBD.
Around 30% of patients with ulcerative colitis (UC) undergo colectomy with ileal pouch-anal anastomosis (IPAA) surgery, and up to 50% of patients develop at least one episode of pouchitis. So, rising prevalence of ulcerative colitis is boosting the America pouchitis treatment market. The prevalence of ulcerative colitis is reported to be 37 to 246 cases per 100,000 individuals whereas, the incidence rate is found to be 2.2 to 14.3 cases per 100,000 people.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian